Follow the Funding, August 2017

This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.

Milestone Pharmaceuticals Montreal Canada, Inc. Novo Holdings A/S, Forbion Capital Partners, Tekla Capital Management, Domain Associates, Fonds de solidarite FTQ, BDC Capital, Pappas Capital and GO Capital$55 million Series CAugust 1, 2017
Homology Medicines, Inc.Deerfield Management, Fidelity Management, HBM Healthcare Investments, Maverick Ventures, Novartis, Rock Springs Capital, Vida Ventures, Vivo Capital and Alexandria Venture Investments. Also, 5AM Ventures, ARCH Venture Partners and Temasek.$83.5 million Series BAugust 1, 2017
easyScriptsBluff Point Associates$2 million Series AAugust 2, 2017
Amplyx PharmaceuticalsSofinnova Venture Partners, Lundbeckfonden Ventures, Arix Bioscience, Pappas Capital, New Enterprise Associates, RiverVest Venture Partners, 3x5 RiverVest II and BioMed Ventures$67 million Series CAugust 2, 2017
Fruit Street HealthPhysician investors$3 million equity investmentAugust 2, 2017
Buoy HealthF-Prime Capital Partners and FundRx$6.7 million Series AAugust 9, 2017
Happify HealthTT Capital Partners$9 millionAugust 15, 2017
HealthJoyChicago Ventures, Social Capital, SidekickFun and GoHealth$3 million Series AAugust 15, 2017
Artemis HealthF-Prime Capital, Maverick Ventures and Kickstart Seed Fund$16 million Series BAugust 16, 2017
Stride HealthF-Prime Capital Partners, Venrock and New Enterprise Associats, as well as Portag3 Ventures$23.5 million Series BAugust 22, 2017
GNS HealthcareAmgen Ventures$6 million equity investmentAugust 23, 2017
FreenomeSection 32$7 million add-on Series AAugust 28, 2017
MedgenomeSequoia India and Sofina, with Zodius Capital, Kris Gopalakrishnan and Lakshmi Narayanan$30 million Series CAugust 28, 2017
SetPoint MedicalNew Enterprise Associates, Morgenthaler, Medtronic, Boston Scientific, Topspin and Action Potential Venture Capital$30 million Series DAugust 28, 2017



Leave a Reply

Your email address will not be published. Required fields are marked *